The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to researchers.
For informational purposes only. Consult a medical professional for advice. Source: Focus Medica. An inflammatory joint disease affecting children below 16 years. It causes joint pain, swelling ...
Few, if any, areas of medical therapeutics have witnessed such dramatic changes as those that have occurred in the therapy of rheumatoid arthritis (RA) during the past two decades. Improvements in ...
Changes in the gut microbiome before rheumatoid arthritis is developed could provide a window of opportunity for preventative treatments, new research suggests. Changes in the make-up of the gut ...
Manchester researchers and Pharmacy Research UK (PRUK) have published research exhibiting the valued role pharmacists can play in supporting young people with juvenile arthritis to self-manage their ...